Contacto
Líneas de investigación
• Investigación y desarrollo de inmunomoduladores para uso humanos.
• Investigación, innovación y desarrollo de anticuerpos para uso diagnóstico y/o terapéutico en humanos.
• Investigación preclínica y clínica de farmoquímicos y biotecnológicos.
• Mejora y optimización regulatoria en biotecnológicos y productos medicinales de terapias avanzadas.
• Desarrollo y evaluación de Terapias celulares
Publicaciones
(1) Maldonado-Garcia, JL., Garcia-Mena, LH., Mendieta-Cabrera, D., Pérez-Sanchez, G., Becerril-Villanueva, E., Alvarez-Herrera, S., Homberg, T., Vallejo-Castilllo, L., Pérez-Tapia, SM., Moreno-Lafont, MC., Ortuño-Sahagún, D., Lenin-Pavón (2024) Use of Extracellular Monomeric Ubiquitin as a Therapeutic Option for Major Depressive Disorder. Pharmaceuticals. 17 https://doi.org/10.3390/ph17070841
Factor de impacto: 4.3
(2) Romo-Rodríguez, R., Zamora-Herrera, G., López-Blanco, J. A., López-García, L., Rosas-Cruz, A., Alfaro-Hernández, L., Trejo-Pichardo, C. O., Alberto-Aguilar, D. R., Casique-Aguirre, D., Vilchis-Ordoñez, A., Solis-Poblano, J. C., García-Stivalet, L. A., Terán-Cerqueda, V., Luna-Silva, N. C., Garrido-Hernández, M. Á., Cano-Cuapio, L. S., Ayala-Contreras, K., Domínguez, F., Del Campo-Martínez, M. L. Á., Juárez-Avendaño, G., … Pelayo, R. (2024). Subclassification of B-acute lymphoblastic leukemia according to age, immunophenotype and microenvironment, predicts MRD risk in Mexican children from vulnerable regions. Frontiers in oncology, 13, 1304662. https://doi.org/10.3389/fonc.2023.1304662
(3) Islas-Vazquez L, Alvarado-Alvarado YC, Cruz-Aguilar M, Velazquez-Soto H, Villalobos-Gonzalez E, Ornelas-Hall G, Perez-Tapia SM y Jimenez-Martinez MC. (2023). Evaluation of the Abdala Vaccine: Antibody and Cellular Response to the RBD Domain of SARS-CoV-2. Vaccines. 11(12):1787.
(4) Godinez-Palma S, Gonzalez-Gonzalez E, Ramirez-Villedas F, Garzón-Guzman C, Vallejo-Castillo L, Carballo-Uicab G. Efficacy, pharmacokinetics, and toxxicity profiles of a broad anti-SARS-CoV-2 Neutralizing Antibody. 2023;8(15):1733
(5) Alnaqbi KA, Bellanger A, Brill A, Castañeda-Hernadez G, Estela AC, Delgado-Sanchez O, et al. An international comparative analysis and roadmap to sustainable biosimilar markets. Frontiers in Pharmacology. 2023; 14.
(6) Homberg TA, Lara I, Andaluz C, Cervantes-Trujano E, Hernandez-Martinez PM, Perez-Tapia SM, et al. Quality of life in adult patients using dialyzable leukocyte extract for allergic rinitis. Medicine;102(27).
(7) Mendoza-Ramírez NJ, García-Cordero J, Martínez-Frías SP, Roa-Velázquez D, Luria-Pérez R, Bustos-Arriaga J, et al. Combination of recombinant proteins S1/N and RBD/N as potential vaccine candidates. Vaccines. 2023;11(4):864.
(8) Guzmán-Bringas OU, Gómez-Castellano KM, González-González E, Salinas-Trujano J, Vázquez-Leyva S, Vallejo-Castillo L, et al. Discovery and Optimization of Neutralizing SARS-CoV-2 Antibodies Using ALTHEA Gold Plus LibrariesTM. International Journal of Molecular Sciences [Internet]. 2023;24(5):4609.
Factor de impacto: 6.208
CITA A: 0
CITA B: 0
(9) Dominguez-Flores A, Rodríguez López GM, Soria-Castro R, López-Santiago R, Rodríguez-Cortés O, Pérez-Tapia SM, et al. Brucella abortus induces mast cell activation through TLR-2 and TLR-4. Microb Pathog 2023;176.
Factor de Impacto: 3.848
CITA A: 0
CITA B: 0
(10) Guerrero-Rodríguez SL, Mata-Cruz C, Pérez-Tapia SM, Velasco-Velázquez MA. Role of CD36 in cancer progression, stemness, and targeting. Front Cell Dev Biol 2022;10.
Factor de impacto: 6.081
CITA A: 0
CITA B: 0
(11) Soria-Castro R, Meneses-Preza YG, Rodríguez-López GM, Ibarra-Sánchez A, González-Espinosa C, Pérez-Tapia SM, et al. Valproic acid restricts mast cell activation by Listeria monocytogenes. Sci Rep 2022;12(1).
Factor de impacto: 5.516
CITA A: 0
CITA B: 1
(12) Muñoz AI, Maldonado-García JL, Fragozo A, Vallejo-Castillo L, Lucas-Gonzalez A, Trejo-Martínez I, et al. Altered neutrophil-to-lymphocyte ratio in sepsis secondary to canine parvoviral enteritis treated with and without an immunomodulator in puppies. Front Vet Sci 2022;9.
Factor de impacto: 3.471
CITA A: 0
CITA B: 0
(13) Hernández-Solis A, Güemes-González AM, Ruiz-Gómez X, Álvarez-Maldonado P, Castañeda-Casimiro J, Flores-López A, et al. IL-6, IL-10, sFas, granulysin and indicators of intestinal permeability as early biomarkers for a fatal outcome in COVID-19. Immunobiology 2022;227(6).
Factor de impacto: 3.152
CITA A: 0
CITA B: 0
(14) Islas-Vazquez L, Cruz-Aguilar M, Velazquez-Soto H, Jiménez-Corona A, Pérez-Tapia SM, Jimenez-Martinez MC. Effector-Memory B-Lymphocytes and Follicular Helper T-Lymphocytes as Central Players in the Immune Response in Vaccinated and Nonvaccinated Populations against SARS-CoV-2. Vaccines 2022;10(10).
Factor de impacto: 4.961
CITA A: 0
CITA B: 0
(15) García-Rocha R, Monroy-García A, Carrera-Martínez M, Hernández-Montes J, Don-López CA, Weiss-Steider B, et al. Evidence that cervical cancer cells cultured as tumorspheres maintain high CD73 expression and increase their protumor characteristics through TGF-β production. Cell Biochem Funct 2022;40(7):760-772.
Factor de impacto: 3.963
CITA A: 0
CITA B: 1
(16) González-González E, Carballo-Uicab G, Salinas-Trujano J, Cortés-Paniagua MI, Vázquez-Leyva S, Vallejo-Castillo L, et al. In Vitro and In Vivo Characterization of a Broadly Neutralizing Anti-SARS-CoV-2 Antibody Isolated from a Semi-Immune Phage Display Library. Antibodies 2022;11(3).
Factor de impacto: N/A
CITA A: 0
CITA B: 0
(17) Almagro JC, Mellado-Sánchez G, Pedraza-Escalona M, Pérez-Tapia SM. Evolution of Anti-SARS-CoV-2 Therapeutic Antibodies. Int J Mol Sci 2022;23(17).
Factor de impacto: 6.208
CITA A: 3
CITA B: 1
(18) Velazquez-Soto H, Miguel FR-, Pérez-Tapia SM, Jiménez-Martínez MC. Kinetic Changes in B7 Costimulatory Molecules and IRF4 Expression in Human Dendritic Cells during LPS Exposure. Biomolecules 2022;12(7).
Factor de impacto: 6.064
CITA A: 0
CITA B: 0
(19) Martínez-Torres I, Tepale-Segura A, Castro-Escamilla O, Cancino-Diaz JC, Rodríguez-Martínez S, Perez-Tapia SM, et al. The Protective Role of pVHL in Imiquimod-Induced Psoriasis-like Skin Inflammation. Int J Mol Sci 2022;23(9).
Factor de impacto: 6.208
CITA A: 1
CITA B: 0
(20) Olivas-Aguirre M, Torres-López L, Villatoro-Gómez K, Perez-Tapia SM, Pottosin I, Dobrovinskaya O. Cannabidiol on the Path from the Lab to the Cancer Patient: Opportunities and Challenges. Pharmaceuticals 2022;15(3).
Factor de impacto: 5.215
CITA A: 3
CITA B: 0
(21) Mendoza-Salazar I, Gómez-Castellano KM, González-González E, Gamboa-Suasnavart R, Rodríguez-Luna SD, Santiago-Casas G, et al. Anti-SARS-CoV-2 Omicron Antibodies Isolated from a SARS-CoV-2 Delta Semi-Immune Phage Display Library. Antibodies 2022;11(1).
Factor de impacto: N/A
CITA A: 1
CITA B: 1
(22) Torres-Pérez SA, Vallejo-Castillo L, Vázquez-Leyva S, Zepeda-Vallejo LG, Herbert-Pucheta JE, Severac C, et al. Structural and physicochemical characteristics of one-step PAMAM dendrimeric nanoparticles. Colloids Surf A Physicochem Eng Asp 2022;633.
Factor de impacto: 5.518
CITA A: 1
CITA B: 0
(23) Magaña-Guerrero FS, Trujillo DH, Buentello-Volante B, Aguayo-Flores JE, Melgoza-González EA, Hernández J, et al. SARS-CoV-2 Seroprevalence among the Health Care Staff of an Ophthalmological Reference Centre, a Cross Sectional Study. Ophthalmic Epidemiol 2022;29(5):483-490.
Factor de impacto: 2.099
CITA A: 1
CITA B: 1
(24) Pedraza-Escalona M, Guzmán-Bringas O, Arrieta-Oliva HI, Gómez-Castellano K, Salinas-Trujano J, Torres-Flores J, et al. Isolation and characterization of high affinity and highly stable anti-Chikungunya virus antibodies using ALTHEA Gold Libraries™. BMC Infect Dis 2021;21(1).
Factor de impacto: 3.714
CITA A: 0
CITA B: 0
(25) Muñoz AI, Vallejo-Castillo L, Fragozo A, Vázquez-Leyva S, Pavón L, Pérez-Sánchez G, et al. Increased survival in puppies affected by Canine Parvovirus type II using an immunomodulator as a therapeutic aid. Sci Rep 2021;11(1).
Factor de impacto: 5.516
CITA A: 2
CITA B: 1
(26) Balandrán JC, Dávila-Velderrain J, Sandoval-Cabrera A, Zamora-Herrera G, Terán-Cerqueda V, García-Stivalet LA, et al. Patient-Derived Bone Marrow Spheroids Reveal Leukemia-Initiating Cells Supported by Mesenchymal Hypoxic Niches in Pediatric B-ALL. Front Immunol 2021;12.
Factor de impacto: 8.786
CITA A: 3
CITA B: 1
(27) Rahalkar H, Sheppard A, Santos GML, Dasgupta C, Perez-Tapia SM, Lopez-Morales CA, et al. Current Regulatory Requirements for Biosimilars in Six Member Countries of BRICS-TM: Challenges and Opportunities. Front Med 2021;8.
Factor de impacto: 5.058
CITA A: 3
CITA B: 1
(28) Maldonado-García JL, Pérez-Sánchez G, Villanueva EB, Alvarez-Herrera S, Pavón L, Gutiérrez-Ospina G, et al. Behavioral and neurochemical shifts at the hippocampus and frontal cortex are associated to peripheral inflammation in balb/c mice infected with brucella abortus 2308. Microorg 2021;9(9).
Factor de impacto: 4.926
CITA A: 0
CITA B: 1
(29) Soria-Castro R, Meneses-Preza YG, Rodríguez-López GM, Romero-Ramírez S, Sosa-Hernández VA, Cervantes-Díaz R, et al. Severe COVID-19 is marked by dysregulated serum levels of carboxypeptidase A3 and serotonin. J Leukocyte Biol 2021;110(3):425-431.
Factor de impacto: 6.011
CITA A: 20
CITA B: 3
(30) Camacho-Sandoval R, Nieto-Patlán A, Carballo-Uicab G, Montes-Luna A, Jiménez-Martínez MC, Vallejo-Castillo L, et al. Development and evaluation of a set of spike and receptor binding domain-based enzyme-linked immunosorbent assays for sars-cov-2 serological testing. Diagn 2021;11(8).
Factor de impacto: 3.992
CITA A: 1
CITA B: 5
(31) Soria-Castro R, Alfaro-Doblado ÁR, Rodríguez-López G, Campillo-Navarro M, Meneses-Preza YG, Galán-Salinas A, et al. TLR2 Regulates Mast Cell IL-6 and IL-13 Production During Listeria monocytogenes Infection. Front Immunol 2021;12.
Factor de impacto: 8.786
CITA A: 1
CITA B: 1
(32) Valdés-Rives SA, Arcos-Montoya D, de la Fuente-Granada M, Zamora-Sánchez CJ, Arias-Romero LE, Villamar-Cruz O, et al. Lpa1 receptor promotes progesterone receptor phosphorylation through pkcα in human glioblastoma cells. Cells 2021;10(4).
Factor de impacto: 7.666
CITA A: 6
CITA B: 1
(33) Herbert-Pucheta JE, López-Morales CA, Medina-Rivero E, Estrada-Parra S, Pérez-Tapia SM, Zepeda-Vallejo LG. Consistency of a dialyzable leucocyte extract manufactured at GMP facilities by nuclear magnetic resonance spectroscopy. J Pharm Biomed Anal 2021;196.
Factor de impacto: 3.571
CITA A: 0
CITA B: 2
(34) Montiel-Cervantes LA, Medina G, Cruz-Domínguez MP, Perez-Tapia S-, Jiménez-Martínez MC, Arrieta-Oliva HI, et al. Poor Survival in COVID-19 Associated with Lymphopenia and Higher Neutrophile-Lymphocyte Ratio. Isr Med Assoc J 2021;23(3):153-159.
Factor de impacto: 1.036
CITA A: 9
CITA B: 2
(35) Romero-Trejo D, Mejía-Rodríguez R, Sierra-Mondragón E, Navarrete A, Pérez-Tapia M, González RO, et al. The systemic administration of neural stem cells expressing an inducible and soluble form of growth arrest specific 1 inhibits mammary gland tumor growth and the formation of metastases. Cytotherapy 2021;23(3):223-235.
Factor de impacto: 6.196
CITA A: 1
CITA B: 2
(36) Mejía-Calvo I, López-Juárez LE, Vázquez-Leyva S, López-Morales CA, Montoya-Escutia D, Merlos Rivera PG, et al. Quality attributes of partially hydrolyzed collagen in a liquid formulation used for skin care. J Cosmet Dermatol 2021;20(1):150-158.
Factor de impacto: 2.189
CITA A: 2
CITA B: 0
(37) Torres-Pérez SA, Torres-Pérez CE, Pedraza-Escalona M, Pérez-Tapia SM, Ramón-Gallegos E. Glycosylated Nanoparticles for Cancer-Targeted Drug Delivery. Front Oncol 2020;10.
Factor de impacto: 5.738
CITA A: 23
CITA B: 0
(38) Vallejo-Castillo L, Favari L, Vázquez-Leyva S, Mellado-Sánchez G, Macías-Palacios Z, López-Juárez LE, et al. Sequencing Analysis and Identification of the Primary Peptide Component of the Dialyzable Leukocyte Extract “Transferon Oral”: The Starting Point to Understand Its Mechanism of Action. Front Pharmacol 2020;11.
Factor de impacto: 5.988
CITA A: 1
CITA B: 2
(39) Rodríguez-López GM, Soria-Castro R, Campillo-Navarro M, Pérez-Tapia SM, Flores-Borja F, Wong-Baeza I, et al. The histone deacetylase inhibitor valproic acid attenuates phospholipase Cγ2 and IgE-mediated mast cell activation. J Leukocyte Biol 2020;108(3):859-866.
Factor de impacto: 6.011
CITA A: 3
CITA B: 3
(40) Vázquez-Sánchez EA, Mendoza-Figueroa JS, Gutiérrez-Gonzalez G, Zapi-Colín LA, Torales-Cardeña A, Briseño-Lugo PE, et al. Heptapeptide HP3 acts as a potent inhibitor of experimental imiquimod-induced murine psoriasis and impedes the trans-endothelial migration of mononuclear cells. Mol Med Rep 2020;22(1):507-515.
Factor de impacto: 3.423
CITA A: 1
CITA B: 0
(41) Zapi-Colín LA, Gutiérrez-González G, Rodríguez-Martínez S, Cancino-Diaz JC, Méndez-Tenorio A, Pérez-Tapia SM, et al. A peptide derived from phage-display limits psoriasis-like lesions in mice. Heliyon 2020;6(6).
Factor de impacto: 3.776
CITA A: 3
CITA B: 0
(42) Gómez-Chávez F, López-Portales ÓH, Baeza-Martínez DA, Cancino-Díaz JC, Murrieta-Coxca JM, Cancino-Díaz ME, et al. IκBNS and IL-6 expression is differentially established in the uterus of pregnant healthy and infected mice. Heliyon 2020;6(6).
Factor de impacto: 3.776
CITA A: 1
CITA B: 2
(43) Olivera-Castillo L, Grant G, Kantún-Moreno N, Barrera-Pérez HA, Montero J, Olvera-Novoa MA, et al. A glycosaminoglycan-rich fraction from sea cucumber isostichopus badionotus has potent anti-inflammatory properties in vitro and in vivo. Nutrients 2020;12(6):1-15.
Factor de impacto: 6.706
CITA A: 7
CITA B: 1
(44) Camacho-Sandoval R, Jiménez-Uribe A, Tenorio-Calvo AV, López-Morales CA, Muñoz-García L, Montes-Luna A, et al. Taking advantage of a high-throughput flow cytometer for the implementation of an ADCC assay for regulatory compliance. Biotechnol Rep 2020;26.
Factor de impacto: N/A
CITA A: 0
CITA B: 0
(45) Melgarejo-Rubio G, Pérez-Tapia SM, Medina-Rivero E, Velasco-Velázquez MA. Antibody-drug conjugates: The new generation of biotechnological therapies against cancer. Gac Med Mex 2020;156(3):228-235.
Factor de impacto: 0.708
CITA A: 2
CITA B: 0
(46) Perdomo-Abúndez FC, Vallejo-Castillo L, Vázquez-Leyva S, López-Morales CA, Velasco-Velázquez M, Pavón L, et al. Development and validation of a mass spectrometric method to determine the identity of rituximab based on its microheterogeneity profile. J Chromatogr B Anal Technol Biomed Life Sci 2020;1139.
Factor de impacto: 3.318
CITA A: 2
CITA B: 2
(47) Muñóz-Godínez R, De Lourdes Mora-García M, Weiss-Steider B, Montesinos-Montesinos JJ, Del Carmen Aguilar-Lemarroy A, García-Rocha R, et al. Detection of CD39 and a Highly Glycosylated Isoform of Soluble CD73 in the Plasma of Patients with Cervical Cancer: Correlation with Disease Progression. Mediators Inflamm 2020;2020.
Factor de impacto:
CITA A: 4
CITA B: 0
(48) Velázquez-Quesada I, Ruiz-Moreno AJ, Casique-Aguirre D, Aguirre-Alvarado C, Cortés-Mendoza F, de la Fuente-Granada M, et al. Pranlukast antagonizes cd49f and reduces stemness in triple-negative breast cancer cells. Drug Des Dev Ther 2020;14:1799-1811.
Factor de impacto: 4.529
CITA A: 2
CITA B: 0
(49) Alanis-Sánchez BM, Pérez-Tapia SM, Vázquez-Leyva S, Mejía-Calvo I, Macías-Palacios Z, Vallejo-Castillo L, et al. Utilization of naproxen by Amycolatopsis sp. Poz 14 and detection of the enzymes involved in the degradation metabolic pathway. World J Microbiol Biotechnol 2019;35(12).
Factor de impacto: 3.277
CITA A: 5
CITA B: 2
(50) Martínez-García S, Ortega-Peña S, De Haro-Cruz MDJ, Aguilera-Arreola MG, Alcántar-Curiel MD, Betanzos-Cabrera G, et al. Non-biofilm-forming commensal Staphylococcus epidermidis isolates produce biofilm in the presence of trypsin. MicrobiologyOpen 2019;8(10).
Factor de impacto:
CITA A: 1
CITA B: 4
(51) Carballo-Uicab G, Linares-Trejo JE, Mellado-Sánchez G, López-Morales CA, Velasco-Velázquez M, Pavón L, et al. Validation of a cell proliferation assay to assess the potency of a dialyzable leukocyte extract intended for batch release. Molecules 2019;24(19).
Factor de impacto: 4.927
CITA A: 0
CITA B: 0
(52) Almagro JC, Pedraza-Escalona M, Arrieta HI, Pérez-Tapia SM. Phage display libraries for antibody therapeutic discovery and development. Antibodies 2019;8(3).
Factor de impacto: N/A
CITA A: 48
CITA B: 3
(53) Avila S, Guerrero-García JDJ, Becerril-Villanueva E, Pérez-Sánchez G, Pavón L, Rojas-Mayorquín AE, et al. A differential sex-specific pattern of IgG2 and IgG4 subclasses of anti-drug antibodies (ADAs) induced by glatiramer acetate in relapsing-remitting multiple sclerosis patients. Mult Scler Relat Disord 2019;34:92-99.
Factor de impacto: 4.808
CITA A: 1
CITA B: 0
(54) Mejía-Calvo I, Muñoz-García L, Jiménez-Uribe A, Camacho-Sandoval R, González-González E, Mellado-Sánchez G, et al. Validation of a cell-based colorimetric reporter gene assay for the evaluation of Type I Interferons. Biotechnol Rep 2019;22.
Factor de impacto: N/A
CITA A: 0
CITA B: 0
(55) Vásquez-Bochm LX, Velázquez-Paniagua M, Castro-Vázquez SS, Guerrero-Rodríguez SL, Mondragon-Peralta A, De La Fuente-Granada M, et al. Transcriptome-based identification of lovastatin as a breast cancer stem cell-targeting drug. Pharmacol Rep 2019;71(3):535-544.
Factor de impacto: 3.919
CITA A: 18
CITA B: 2
(56) Ramírez-Ramírez D, Padilla-Castañeda S, Galán-Enríquez CS, Vadillo E, Prieto-Chávez JL, Jiménez-Hernández E, et al. CRTAM + NK cells endowed with suppressor properties arise in leukemic bone marrow. J Leukocyte Biol 2019;105(5):999-1013.
Factor de impacto: 6.011
CITA A: 5
CITA B: 3
(57) Valadon P, Pérez-Tapia SM, Nelson RS, Guzmán-Bringas OU, Arrieta-Oliva HI, Gómez-Castellano KM, et al. ALTHEA Gold Libraries™: antibody libraries for therapeutic antibody discovery. mAbs 2019;11(3):516-531.
Factor de impacto: 6.440
CITA A: 12
CITA B: 5
(58) Ávila-Ibarra LR, Mora-Garcia MDL, García-Rocha R, Hernández-Montes J, Weiss-Steider B, Montesinos JJ, et al. Mesenchymal Stromal Cells Derived from Normal Cervix and Cervical Cancer Tumors Increase CD73 Expression in Cervical Cancer Cells Through TGF-β1 Production. Stem Cells Dev 2019;28(7):477-488.
Factor de impacto: 4.390
CITA A: 11
CITA B: 0
(59) López-Morales CA, Vázquez-Leyva S, Vallejo-Castillo L, Carballo-Uicab G, Muñoz-García L, Herbert-Pucheta JE, et al. Determination of Peptide Profile Consistency and Safety of Collagen Hydrolysates as Quality Attributes. J Food Sci 2019;84(3):430-439.
Factor de impacto: 3.693
CITA A: 7
CITA B: 6
(60) Martínez-García S, Ortiz-García CI, Cruz-Aguilar M, Zenteno JC, Murrieta-Coxca JM, Pérez-Tapia SM, et al. Competition/antagonism associations of biofilm formation among Staphylococcus epidermidis Agr groups I, II, and III. J Microbiol 2019;57(2):143-153.
Factor de impacto: 2.902
CITA A: 3
CITA B: 2
(61) Vázquez-Leyva S, Vallejo-Castillo L, López-Morales CA, Herbert-Pucheta JE, Zepeda-Vallejo LG, Velasco-Velázquez M, et al. Identity Profiling of Complex Mixtures of Peptide Products by Structural and Mass Mobility Orthogonal Analysis. Anal Chem 2019.
Factor de impacto: 1.237
CITA A: 4
CITA B: 6
(62) Velasco-Velázquez MA, Velázquez-Quesada I, Vásquez-Bochm LX, Pérez-Tapia SM. Targeting breast cancer stem cells: A methodological perspective. Curr Stem Cell Res Ther 2019;14(5):389-397.
Factor de impacto: 8.393
CITA A: 1
CITA B: 3
(63) Mellado-Sánchez G, Lázaro-Rodríguez JJ, Avila S, Vallejo-Castillo L, Vázquez-Leyva S, Carballo-Uicab G, et al. Development of functional antibodies directed to human dialyzable leukocyte extract (Transferon®). J Immunol Res 2019;2019.
Factor de impacto: 4.493
CITA A: 0
CITA B: 1
(64) Jiménez-Uribe AP, Valencia-Martínez H, Carballo-Uicab G, Vallejo-Castillo L, Medina-Rivero E, Chacón-Salinas R, et al. CD80 expression correlates with IL-6 production in THP-1-like macrophages costimulated with LPS and dialyzable leukocyte extract (Transferon®). J Immunol Res 2019;2019.
Factor de impacto: 4.493
CITA A: 12
CITA B: 2
(65) De Lourdes Mora-García M, López-Cisneros S, Gutiérrez-Serrano V, García-Rocha R, Weiss-Steider B, Hernández-Montes J, et al. HPV-16 Infection Is Associated with a High Content of CD39 and CD73 Ectonucleotidases in Cervical Samples from Patients with CIN-1. Mediators Inflamm 2019;2019.
Factor de impacto: 4.529
CITA A: 10
CITA B: 1
(66) Nieto-Patlán E, Serafín-López J, Wong-Baeza I, Pérez-Tapia SM, Cobos-Marín L, Estrada-Parra S, et al. Valproic acid promotes a decrease in mycobacterial survival by enhancing nitric oxide production in macrophages stimulated with IFN-γ. Tuberculosis 2019;114:123-126.
Factor de impacto: 2.973
CITA A: 11
CITA B: 3
(67) González-González E, Camacho-Sandoval R, Jiménez-Uribe A, Montes-Luna A, Cortés-Paniagua I, Sánchez-Morales J, et al. Validation of an ADCC assay using human primary natural killer cells to evaluate biotherapeutic products bearing an Fc region. J Immunol Methods 2019;464:87-94.
Factor de impacto: 2.287
CITA A: 4
CITA B: 1
